Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Radionetics Oncology Closes $52.5 M Series A

2024-01-05
SAN DIEGO, CA, Radionetics Oncology closes $52.2M Series A funding led by Frazier Life Sciences, 5AM Ventures and DCVC Bio.
Radionetics Oncology closes $52.2M Series A funding led by Frazier Life Sciences, 5AM Ventures and DCVC Bio with additional support from Crinetics Pharmaceuticals, and GordonMD Global Investments.

Radionetics plans to use the proceeds to advance its pipeline of potent, small molecule radiopharmaceuticals targeting novel G-protein coupled receptors (GPCRs) for the treatment of a broad range of cancers.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors